Seneca Biopharma, Inc. SNCA
No live quote for SNCA yet.
Top institutional holders| Holder | % held | Shares | Value | Reported |
|---|
| Renaissance Technologies, LLC | 0.97% | 167,512 | 147.41K | Dec 30, 2020 |
| Virtu Financial LLC | 0.71% | 123,558 | 108.73K | Dec 30, 2020 |
| HighTower Advisors, LLC | 0.58% | 100,005 | 88.00K | Dec 30, 2020 |
| Bank Of New York Mellon Corporation | 0.27% | 47,346 | 41.66K | Dec 30, 2020 |
| Tower Research Capital LLC (TRC) | 0.24% | 42,321 | 37.24K | Dec 30, 2020 |
| Vanguard Group, Inc. (The) | 0.21% | 36,777 | 32.36K | Dec 30, 2020 |
Top mutual fund holders| Holder | % held | Shares | Value | Reported |
|---|
| Fidelity Extended Market Index Fund | 0.68% | 117,971 | 158.08K | Feb 27, 2021 |
| Vanguard Extended Market Index Fund | 0.05% | 8,277 | 7.28K | Dec 30, 2020 |
| USAA Mutual Fd Tr-Extended Market Index Fd | 0.02% | 2,868 | 2.52K | Dec 30, 2020 |
SNCA insiders| Insider | Relation | Latest transaction | Date | Shares held |
|---|
| CONRON JOHN | Chief Financial Officer | Stock Award(Grant) | Jan 27, 2011 | 115,492 |
| GARR I RICHARD | Chief Executive Officer | Conversion of Exercise of derivative security | Jan 26, 2016 | 1,449,800 |
| JOHE KARL | Officer and Director | Conversion of Exercise of derivative security | Nov 18, 2015 | 930,373 |
| OGILVIE SCOTT VARDE | Director | Stock Award(Grant) | Jun 30, 2015 | 86,020 |
| OLDAKER WILLIAM CLYDE | Director | Stock Award(Grant) | Jul 13, 2017 | 33,763 |
| SMITH SANDFORD D | Director | Stock Award(Grant) | Jun 30, 2019 | 219,916 |
